Search research articles
Contact Us
Filters
Showing results (101-110 of 640) with videos related to
Page
of 64
Sort By:
Enzyme
|
January 1, 1986
Computer analysis of enzyme-substrate-inhibitor kinetic data with automatic model selection using IBM-PC compatible microcomputers
R A Lutz, C Bull, D Rodbard
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 12, 2010
Reduced fasting-induced activation of hypothalamic arcuate neurons is associated with hyperleptinemia and increased leptin sensitivity in obese mice
Csilla Becskei, Thomas A Lutz, Thomas Riediger
Life Sciences
|
May 19, 1998
Hyperpolarization of the rat hepatocyte membrane by 2,5-anhydro-D-mannitol in vivo
T A Lutz, S Boutellier, E Scharrer
Journal of Receptor and Signal Transduction Research
|
January 1, 1995
Kinetic analysis of ligand-receptor association data that display an overshoot phenomenon
R A Lutz, M Kopp, V Pliska
Journal of the Autonomic Nervous System
|
November 6, 1996
Intraportal infusion of 2,5-anhydro-D-mannitol increases afferent activity in the common hepatic vagus branch
T A Lutz, A Niijima, E Scharrer
Neuroendocrinology
|
October 22, 2009
Blunted fasting-induced hypothalamic activation and refeeding hyperphagia in late-onset obesity
Csilla Becskei, Thomas A Lutz, Thomas Riediger
Bulletin De L'Academie De Medecine
|
March 19, 2010
Stabilization test of human plasma by the combined action of formalin and heat; formoplasma
R DUJARRIC de la RIVIERE, A LUTZ
Hospital Practice (1995)
|
March 13, 2012
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model
Manfred A Lutz, Pedro Lovato, Genaro Cuesta
Nature Metabolism
|
February 18, 2026
The story of amylin: from physiology to therapy
Anna Secher, Thomas A Lutz, Kirsten Raun
Expert Review of Endocrinology & Metabolism
|
May 8, 2026
What is the role of amylin as an emerging therapeutic agent in obesity?
Guillaume Bogaerts, Greta Lommi, Thomas A Lutz
Page
of 64
Search research articles
Search
Showing results (101-110 of 640) with videos related to
Sort By:
Page
of 64
Enzyme
|
January 1, 1986
Computer analysis of enzyme-substrate-inhibitor kinetic data with automatic model selection using IBM-PC compatible microcomputers
R A Lutz, C Bull, D Rodbard
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 12, 2010
Reduced fasting-induced activation of hypothalamic arcuate neurons is associated with hyperleptinemia and increased leptin sensitivity in obese mice
Csilla Becskei, Thomas A Lutz, Thomas Riediger
Life Sciences
|
May 19, 1998
Hyperpolarization of the rat hepatocyte membrane by 2,5-anhydro-D-mannitol in vivo
T A Lutz, S Boutellier, E Scharrer
Journal of Receptor and Signal Transduction Research
|
January 1, 1995
Kinetic analysis of ligand-receptor association data that display an overshoot phenomenon
R A Lutz, M Kopp, V Pliska
Journal of the Autonomic Nervous System
|
November 6, 1996
Intraportal infusion of 2,5-anhydro-D-mannitol increases afferent activity in the common hepatic vagus branch
T A Lutz, A Niijima, E Scharrer
Neuroendocrinology
|
October 22, 2009
Blunted fasting-induced hypothalamic activation and refeeding hyperphagia in late-onset obesity
Csilla Becskei, Thomas A Lutz, Thomas Riediger
Bulletin De L'Academie De Medecine
|
March 19, 2010
Stabilization test of human plasma by the combined action of formalin and heat; formoplasma
R DUJARRIC de la RIVIERE, A LUTZ
Hospital Practice (1995)
|
March 13, 2012
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model
Manfred A Lutz, Pedro Lovato, Genaro Cuesta
Nature Metabolism
|
February 18, 2026
The story of amylin: from physiology to therapy
Anna Secher, Thomas A Lutz, Kirsten Raun
Expert Review of Endocrinology & Metabolism
|
May 8, 2026
What is the role of amylin as an emerging therapeutic agent in obesity?
Guillaume Bogaerts, Greta Lommi, Thomas A Lutz
Page
of 64